YAP controls cell migration and invasion through a Rho GTPase switch
Science Signaling · 27.05.2025 · 18 (888)
DOI: 10.1126/scisignal.adu3794 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, erschienen am 27.05.2025. Verfasst von Sagar R Shah und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. Hauptthemen laut MEDLINE: Cell Movement, Transcription Factors, Adaptor Proteins, Signal Transducing, rhoA GTP-Binding Protein. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Delineating the mechanisms that control the movement of cells is central to understanding diverse physiological and pathophysiological processes. The transcriptional coactivator YAP is important during development and associated with cancer metastasis. Here, we found that YAP promoted cell migration by modulating a Rho family guanosine triphosphatase (GTPase) switch involving Rac1 and RhoA, which are key regulators of cytoskeletal dynamics. YAP transcriptionally transactivated the gene encoding the Rac1 guanine nucleotide exchange factor TRIO by directly binding to its intronic enhancer. This led to the activation of Rac1 and inhibition of RhoA, which increased cell migration and invasion in vitro and in vivo. This YAP-dependent program was observed across many cell types, including human breast epithelial cells and astrocytes, but it was particularly enhanced in a patient-specific manner in glioblastoma (GBM), the most common malignant brain tumor. Additionally, YAP-TRIO signaling activated STAT3, a transcription factor implicated in invasive growth in cancer, suggesting potential for cross-talk with this pathway to exacerbate invasive behavior. Clinically, hyperactivation of YAP, TRIO, and STAT3 gene signatures in GBM were associated with poor survival outcomes in patients. Our findings suggest that the YAP-TRIO-Rho-GTPase signaling network regulates invasive cell spread in both physiological and pathological contexts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
- Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
- Department of Biomedical Engineering and Yale Systems Biology Institute, Yale University, New Haven, CT 06511, USA.
- CRBM-CNRS, University of Montpellier, 1919 route de Mende, 34293 Montpellier, France.
- Department of Neurology, Kennedy Krieger Institute, Baltimore, MD 21231, USA.
- Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
ORCID-Profile: Sagar R Shah, Chunxiao Ren, Nathaniel D Tippens, JinSeok Park, Shuyan Wang, Juan C Martinez-Gutierrez, Susanne Schmidt, Alfredo Quiñones-Hinojosa, Andre Levchenko
Förderung
- NCI NIH HHS
- NINDS NIH HHS
Zitieren
APA
Shah, S. R., Ren, C., Tippens, N. D., Park, J., Mohyeldin, A., Wang, S., Vela, G., Martinez-Gutierrez, J. C., Margolis, S. S., Schmidt, S., Quiñones-Hinojosa, A., & Levchenko, A. (2025). YAP controls cell migration and invasion through a Rho GTPase switch. Science Signaling, 18(888). https://doi.org/10.1126/scisignal.adu3794
Vancouver
Shah SR, Ren C, Tippens ND, Park J, Mohyeldin A, Wang S, et al. YAP controls cell migration and invasion through a Rho GTPase switch. Science Signaling. 2025;18(888). doi:10.1126/scisignal.adu3794
BibTeX
@article{Shah2025,
author = {Shah, Sagar R and Ren, Chunxiao and Tippens, Nathaniel D and Park, JinSeok and Mohyeldin, Ahmed and Wang, Shuyan and Vela, Guillermo and Martinez-Gutierrez, Juan C and Margolis, Seth S and Schmidt, Susanne and Quiñones-Hinojosa, Alfredo and Levchenko, Andre},
title = {YAP controls cell migration and invasion through a Rho GTPase switch},
journal = {Science Signaling},
year = {2025},
volume = {18},
number = {888},
doi = {10.1126/scisignal.adu3794}
}
EUVIMED